Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

November 01, 1997; Volume 52,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Allan, William P.

    1. You have access
      Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site
      Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich
      Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839
  2. Auchampach, John A.

    1. You have access
      Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor
      John A. Auchampach, Xiaowei Jin, Tina C. Wan, George H. Caughey and Joel Linden
      Molecular Pharmacology November 1997, 52 (5) 846-860; DOI: https://doi.org/10.1124/mol.52.5.846
  3. Awaji, Takeo

    1. You have access
      Subtype-Specific Differences in Subcellular Localization of α1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface α1-Adrenoceptors Irrespective of the Subtype
      Akira Hirasawa, Tatsuo Sugawara, Takeo Awaji, Keiko Tsumaya, Hiroshi Ito and Gozoh Tsujimoto
      Molecular Pharmacology November 1997, 52 (5) 764-770; DOI: https://doi.org/10.1124/mol.52.5.764

B

  1. Bayly, Christopher

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
  2. Bello, Vanessa

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  3. Bialkowski, Karol

    1. You have access
      Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy
      Ryszard Olinski, Pawel Jaruga, Marek Foksinski, Karol Bialkowski and Jerzy Tujakowski
      Molecular Pharmacology November 1997, 52 (5) 882-885; DOI: https://doi.org/10.1124/mol.52.5.882
  4. Brent, Thomas P.

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815

C

  1. Canela, Enric I.

    1. You have access
      Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
      Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco
      Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788
  2. Caughey, George H.

    1. You have access
      Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor
      John A. Auchampach, Xiaowei Jin, Tina C. Wan, George H. Caughey and Joel Linden
      Molecular Pharmacology November 1997, 52 (5) 846-860; DOI: https://doi.org/10.1124/mol.52.5.846
  3. Chen, Zhi-Hao

    1. You have access
      Expression of Methylthioadenosine Phosphorylase cDNA inp16 −, MTAP −Malignant Cells: Restoration of Methylthioadenosine Phosphorylase-Dependent Salvage Pathways and Alterations of Sensitivity to Inhibitors of Purine de novo Synthesis
      Zhi-Hao Chen, Olufunmilayo I. Olopade and Todd M. Savarese
      Molecular Pharmacology November 1997, 52 (5) 903-911; DOI: https://doi.org/10.1124/mol.52.5.903
  4. Chen, Zhong-Ping

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  5. Cherepanov, Peter

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  6. Ciruela, Francisco

    1. You have access
      Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
      Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco
      Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788
  7. Connor, Henry

    1. You have access
      Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
      Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
      Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912
  8. Creighton, Andrew M.

    1. You have access
      Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site
      Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich
      Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839

D

  1. David, Guido

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  2. Debyser, Zeger

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  3. De Clercq, Erik

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771

E

  1. Esté, José A.

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  2. Everts, Inga

    1. You have access
      N-Glycosylation Is Not a Prerequisite for Glutamate Receptor Function but Is Essential for Lectin Modulation
      Inga Everts, Carmen Villmann and Michael Hollmann
      Molecular Pharmacology November 1997, 52 (5) 861-873; DOI: https://doi.org/10.1124/mol.52.5.861

F

  1. Falgueyret, Jean-Pierre

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
  2. Foksinski, Marek

    1. You have access
      Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy
      Ryszard Olinski, Pawel Jaruga, Marek Foksinski, Karol Bialkowski and Jerzy Tujakowski
      Molecular Pharmacology November 1997, 52 (5) 882-885; DOI: https://doi.org/10.1124/mol.52.5.882
  3. Francis, Donna A.

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
  4. Franco, Rafael

    1. You have access
      Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
      Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco
      Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788
  5. Frankenberg, Moritz von

    1. You have access
      Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
      Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
      Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912

G

  1. Greenwood, Michael T.

    1. You have access
      Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
      Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
      Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807
  2. Greig, Gillian M.

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829

H

  1. Hasinoff, Brian B.

    1. You have access
      Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site
      Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich
      Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839
  2. Hirasawa, Akira

    1. You have access
      Subtype-Specific Differences in Subcellular Localization of α1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface α1-Adrenoceptors Irrespective of the Subtype
      Akira Hirasawa, Tatsuo Sugawara, Takeo Awaji, Keiko Tsumaya, Hiroshi Ito and Gozoh Tsujimoto
      Molecular Pharmacology November 1997, 52 (5) 764-770; DOI: https://doi.org/10.1124/mol.52.5.764
  3. Hjorth, Siv A.

    1. You have access
      Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
      Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
      Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807
  4. Hollmann, Michael

    1. You have access
      N-Glycosylation Is Not a Prerequisite for Glutamate Receptor Function but Is Essential for Lectin Modulation
      Inga Everts, Carmen Villmann and Michael Hollmann
      Molecular Pharmacology November 1997, 52 (5) 861-873; DOI: https://doi.org/10.1124/mol.52.5.861
  5. Hukovic, Nedim

    1. You have access
      Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
      Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
      Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807

I

  1. Ito, Hiroshi

    1. You have access
      Subtype-Specific Differences in Subcellular Localization of α1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface α1-Adrenoceptors Irrespective of the Subtype
      Akira Hirasawa, Tatsuo Sugawara, Takeo Awaji, Keiko Tsumaya, Hiroshi Ito and Gozoh Tsujimoto
      Molecular Pharmacology November 1997, 52 (5) 764-770; DOI: https://doi.org/10.1124/mol.52.5.764

J

  1. Jaruga, Pawel

    1. You have access
      Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy
      Ryszard Olinski, Pawel Jaruga, Marek Foksinski, Karol Bialkowski and Jerzy Tujakowski
      Molecular Pharmacology November 1997, 52 (5) 882-885; DOI: https://doi.org/10.1124/mol.52.5.882
  2. Jin, Xiaowei

    1. You have access
      Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor
      John A. Auchampach, Xiaowei Jin, Tina C. Wan, George H. Caughey and Joel Linden
      Molecular Pharmacology November 1997, 52 (5) 846-860; DOI: https://doi.org/10.1124/mol.52.5.846

K

  1. Keating, Michael J.

    1. You have access
      Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance
      Lan Li, Michael J. Keating, William Plunkett and Li-Ying Yang
      Molecular Pharmacology November 1997, 52 (5) 798-806; DOI: https://doi.org/10.1124/mol.52.5.798
  2. Kozlowska, Hanna

    1. You have access
      Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site
      Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich
      Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839
  3. Kumar, Ujendra

    1. You have access
      Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
      Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
      Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807

L

  1. Lemasters, John J.

    1. You have access
      Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
      Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
      Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912
  2. Li, Lan

    1. You have access
      Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance
      Lan Li, Michael J. Keating, William Plunkett and Li-Ying Yang
      Molecular Pharmacology November 1997, 52 (5) 798-806; DOI: https://doi.org/10.1124/mol.52.5.798
  3. Linden, Joel

    1. You have access
      Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor
      John A. Auchampach, Xiaowei Jin, Tina C. Wan, George H. Caughey and Joel Linden
      Molecular Pharmacology November 1997, 52 (5) 846-860; DOI: https://doi.org/10.1124/mol.52.5.846
  4. Lluís, Carmen

    1. You have access
      Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
      Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco
      Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788

M

  1. Malapetsa, Areti

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  2. Mallol, Josefa

    1. You have access
      Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
      Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco
      Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788
  3. Mancini, Joseph A.

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
  4. Marcantonio, Daniela

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  5. Mason, Ronald P.

    1. You have access
      Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
      Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
      Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912
  6. McQuillan, Angela

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  7. Medzihradsky, Fedor

    1. You have access
      Down-regulation of μ-Opioid Receptor by Full but Not Partial Agonists Is Independent of G Protein Coupling
      Nirmala Yabaluri and Fedor Medzihradsky
      Molecular Pharmacology November 1997, 52 (5) 896-902; DOI: https://doi.org/10.1124/mol.52.5.896
  8. Mohr, Gérard

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  9. Montell, Craig

    1. You have access
      New Light on TRP and TRPL
      Craig Montell
      Molecular Pharmacology November 1997, 52 (5) 755-763; DOI: https://doi.org/10.1124/mol.52.5.755
  10. Murakoshi, Hideyuki

    1. You have access
      Phosphorylation of the Kv2.1 K+ Channel Alters Voltage-Dependent Activation
      Hideyuki Murakoshi, Gongyi Shi, Robert H. Scannevin and James S. Trimmer
      Molecular Pharmacology November 1997, 52 (5) 821-828; DOI: https://doi.org/10.1124/mol.52.5.821
  11. Murphy, T. J.

    1. You have access
      The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating Agents
      Xiaofei Wang, Georg Nickenig and T. J. Murphy
      Molecular Pharmacology November 1997, 52 (5) 781-787; DOI: https://doi.org/10.1124/mol.52.5.781

N

  1. Nickenig, Georg

    1. You have access
      The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating Agents
      Xiaofei Wang, Georg Nickenig and T. J. Murphy
      Molecular Pharmacology November 1997, 52 (5) 781-787; DOI: https://doi.org/10.1124/mol.52.5.781

O

  1. O’Neill, Gary P.

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
  2. Ojwang, Joshua O.

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  3. Olinski, Ryszard

    1. You have access
      Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy
      Ryszard Olinski, Pawel Jaruga, Marek Foksinski, Karol Bialkowski and Jerzy Tujakowski
      Molecular Pharmacology November 1997, 52 (5) 882-885; DOI: https://doi.org/10.1124/mol.52.5.882
  4. Olopade, Olufunmilayo I.

    1. You have access
      Expression of Methylthioadenosine Phosphorylase cDNA inp16 −, MTAP −Malignant Cells: Restoration of Methylthioadenosine Phosphorylase-Dependent Salvage Pathways and Alterations of Sensitivity to Inhibitors of Purine de novo Synthesis
      Zhi-Hao Chen, Olufunmilayo I. Olopade and Todd M. Savarese
      Molecular Pharmacology November 1997, 52 (5) 903-911; DOI: https://doi.org/10.1124/mol.52.5.903
  5. Ouellet, Marc

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829

P

  1. Panasci, Lawrence C.

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  2. Panetta, Rosemarie

    1. You have access
      Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
      Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
      Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807
  3. Patel, Yogesh C.

    1. You have access
      Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
      Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
      Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807
  4. Percival, M. David

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
  5. Plunkett, William

    1. You have access
      Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance
      Lan Li, Michael J. Keating, William Plunkett and Li-Ying Yang
      Molecular Pharmacology November 1997, 52 (5) 798-806; DOI: https://doi.org/10.1124/mol.52.5.798

R

  1. Rando, Robert F.

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  2. Reekmans, Gunther

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  3. Remack, Joanna

    1. You have access
      Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
      Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
      Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  4. Roy, Patrick

    1. You have access
      The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
      Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
      Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829

S

  1. Saura, Carles

    1. You have access
      Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
      Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco
      Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788
  2. Savarese, Todd M.

    1. You have access
      Expression of Methylthioadenosine Phosphorylase cDNA inp16 −, MTAP −Malignant Cells: Restoration of Methylthioadenosine Phosphorylase-Dependent Salvage Pathways and Alterations of Sensitivity to Inhibitors of Purine de novo Synthesis
      Zhi-Hao Chen, Olufunmilayo I. Olopade and Todd M. Savarese
      Molecular Pharmacology November 1997, 52 (5) 903-911; DOI: https://doi.org/10.1124/mol.52.5.903
  3. Scannevin, Robert H.

    1. You have access
      Phosphorylation of the Kv2.1 K+ Channel Alters Voltage-Dependent Activation
      Hideyuki Murakoshi, Gongyi Shi, Robert H. Scannevin and James S. Trimmer
      Molecular Pharmacology November 1997, 52 (5) 821-828; DOI: https://doi.org/10.1124/mol.52.5.821
  4. Shi, Gongyi

    1. You have access
      Phosphorylation of the Kv2.1 K+ Channel Alters Voltage-Dependent Activation
      Hideyuki Murakoshi, Gongyi Shi, Robert H. Scannevin and James S. Trimmer
      Molecular Pharmacology November 1997, 52 (5) 821-828; DOI: https://doi.org/10.1124/mol.52.5.821
  5. Srikant, Coimbatore B.

    1. You have access
      Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
      Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
      Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807
  6. Stachlewitz, Robert F.

    1. You have access
      Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
      Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
      Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912
  7. Steinfeld, Robert

    1. You have access
      Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
      Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
      Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  8. Sugawara, Tatsuo

    1. You have access
      Subtype-Specific Differences in Subcellular Localization of α1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface α1-Adrenoceptors Irrespective of the Subtype
      Akira Hirasawa, Tatsuo Sugawara, Takeo Awaji, Keiko Tsumaya, Hiroshi Ito and Gozoh Tsujimoto
      Molecular Pharmacology November 1997, 52 (5) 764-770; DOI: https://doi.org/10.1124/mol.52.5.764

T

  1. Thampatty, Padmakumari

    1. You have access
      Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site
      Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich
      Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839
  2. Thompson, Sally A.

    1. You have access
      Key Amino Acids in the γ Subunit of the γ-Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site
      Peter B. Wingrove, Sally A. Thompson, Keith A. Wafford and Paul J. Whiting
      Molecular Pharmacology November 1997, 52 (5) 874-881; DOI: https://doi.org/10.1124/mol.52.5.874
  3. Thurman, Ronald G.

    1. You have access
      Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
      Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
      Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912
  4. Trimmer, James S.

    1. You have access
      Phosphorylation of the Kv2.1 K+ Channel Alters Voltage-Dependent Activation
      Hideyuki Murakoshi, Gongyi Shi, Robert H. Scannevin and James S. Trimmer
      Molecular Pharmacology November 1997, 52 (5) 821-828; DOI: https://doi.org/10.1124/mol.52.5.821
  5. Tsujimoto, Gozoh

    1. You have access
      Subtype-Specific Differences in Subcellular Localization of α1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface α1-Adrenoceptors Irrespective of the Subtype
      Akira Hirasawa, Tatsuo Sugawara, Takeo Awaji, Keiko Tsumaya, Hiroshi Ito and Gozoh Tsujimoto
      Molecular Pharmacology November 1997, 52 (5) 764-770; DOI: https://doi.org/10.1124/mol.52.5.764
  6. Tsumaya, Keiko

    1. You have access
      Subtype-Specific Differences in Subcellular Localization of α1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface α1-Adrenoceptors Irrespective of the Subtype
      Akira Hirasawa, Tatsuo Sugawara, Takeo Awaji, Keiko Tsumaya, Hiroshi Ito and Gozoh Tsujimoto
      Molecular Pharmacology November 1997, 52 (5) 764-770; DOI: https://doi.org/10.1124/mol.52.5.764
  7. Tujakowski, Jerzy

    1. You have access
      Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy
      Ryszard Olinski, Pawel Jaruga, Marek Foksinski, Karol Bialkowski and Jerzy Tujakowski
      Molecular Pharmacology November 1997, 52 (5) 882-885; DOI: https://doi.org/10.1124/mol.52.5.882

V

  1. Vijverberg, Henk P. M.

    1. You have access
      Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects
      Ruud Zwart and Henk P. M. Vijverberg
      Molecular Pharmacology November 1997, 52 (5) 886-895; DOI: https://doi.org/10.1124/mol.52.5.886
  2. Villmann, Carmen

    1. You have access
      N-Glycosylation Is Not a Prerequisite for Glutamate Receptor Function but Is Essential for Lectin Modulation
      Inga Everts, Carmen Villmann and Michael Hollmann
      Molecular Pharmacology November 1997, 52 (5) 861-873; DOI: https://doi.org/10.1124/mol.52.5.861

W

  1. Wafford, Keith A.

    1. You have access
      Key Amino Acids in the γ Subunit of the γ-Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site
      Peter B. Wingrove, Sally A. Thompson, Keith A. Wafford and Paul J. Whiting
      Molecular Pharmacology November 1997, 52 (5) 874-881; DOI: https://doi.org/10.1124/mol.52.5.874
  2. Wan, Tina C.

    1. You have access
      Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor
      John A. Auchampach, Xiaowei Jin, Tina C. Wan, George H. Caughey and Joel Linden
      Molecular Pharmacology November 1997, 52 (5) 846-860; DOI: https://doi.org/10.1124/mol.52.5.846
  3. Wang, Xiaofei

    1. You have access
      The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating Agents
      Xiaofei Wang, Georg Nickenig and T. J. Murphy
      Molecular Pharmacology November 1997, 52 (5) 781-787; DOI: https://doi.org/10.1124/mol.52.5.781
  4. Whiting, Paul J.

    1. You have access
      Key Amino Acids in the γ Subunit of the γ-Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site
      Peter B. Wingrove, Sally A. Thompson, Keith A. Wafford and Paul J. Whiting
      Molecular Pharmacology November 1997, 52 (5) 874-881; DOI: https://doi.org/10.1124/mol.52.5.874
  5. Wingrove, Peter B.

    1. You have access
      Key Amino Acids in the γ Subunit of the γ-Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site
      Peter B. Wingrove, Sally A. Thompson, Keith A. Wafford and Paul J. Whiting
      Molecular Pharmacology November 1997, 52 (5) 874-881; DOI: https://doi.org/10.1124/mol.52.5.874

Y

  1. Yabaluri, Nirmala

    1. You have access
      Down-regulation of μ-Opioid Receptor by Full but Not Partial Agonists Is Independent of G Protein Coupling
      Nirmala Yabaluri and Fedor Medzihradsky
      Molecular Pharmacology November 1997, 52 (5) 896-902; DOI: https://doi.org/10.1124/mol.52.5.896
  2. Yalowich, Jack C.

    1. You have access
      Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site
      Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich
      Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839
  3. Yang, Li-Ying

    1. You have access
      Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance
      Lan Li, Michael J. Keating, William Plunkett and Li-Ying Yang
      Molecular Pharmacology November 1997, 52 (5) 798-806; DOI: https://doi.org/10.1124/mol.52.5.798

Z

  1. Zhong, Zhi

    1. You have access
      Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
      Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
      Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912
  2. Zwart, Ruud

    1. You have access
      Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects
      Ruud Zwart and Henk P. M. Vijverberg
      Molecular Pharmacology November 1997, 52 (5) 886-895; DOI: https://doi.org/10.1124/mol.52.5.886
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 52 (5)
Molecular Pharmacology
Vol. 52, Issue 5
1 Nov 1997
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics